Latin America Atherectomy Devices Market

Latin America Atherectomy Devices Market Size (2023 to 2028)

The Latin America atherectomy devices market is forecasted to be worth USD 50.94 million by 2028 from USD 37.35 million in 2023, growing at a CAGR of 6.40% during the forecast period. The market is showcasing evident potential in the mentioned forecasting period. The market continues to gain momentum with rapid development in the medical industry.

The growing inclination for minimally invasive operations drives the market for atherectomy devices in the Latin American region. The presence of a large target patient population recovering from peripheral artery disease and hospitals requiring central vascular access in ICUs, outpatients, CathLabs, and operation theatres is expected to provide manufacturers in the Latin America atherectomy devices market with numerous growth opportunities. In contrast to traditional open surgery, surgeons utilize various techniques to operate with minimum damage to the body in minimally invasive surgery. Other growth-inducing elements include product innovations such as the invention of drug-coated balloons (DCB). With directional atherectomy and anti-restenosis treatment (DAART), DCBs are utilized in place of permanent implants to supply anti-proliferative medicines and treat lesions with severe calcifications.

The directional atherectomy type of the market is projected to expand faster than other products in the coming years, owing to benefits such as lower treatment costs, increased efficiency, and so on. Other factors that are likely to help expand the atherectomy devices market include continued product research and commercialization, attractive medical reimbursement scenarios in mature markets, and the strengthening of distribution channels of key product manufacturers. In the near future, the atherectomy devices market is projected to be driven by rising demand for vascular and coronary intervention due to increased Peripheral Artery Diseases (PADs) and Coronary Artery Diseases (CADs) in recent years. In addition, diabetes, critical limb ischemia, and cardiovascular illnesses have all become more common in recent years, especially among younger people.

Post-operative complications and a scarcity of trained medical personnel are restricting the Latin American atherectomy device market expansion. In addition, high research and development costs and high-quality equipment for lazier processes, and stringent government regulations are likely to hinder Latin American atherectomy devices market expansion.

This research report on the Latin America Atherectomy Devices Market has been segmented and sub-segmented into the following categories:

By Type: 

• Directional
• Rotational
• Orbital
• Lateral

By Application: 

• Peripheral
• Cardiovascular
• Neurovascular

By End User: 

• Hospitals
• Surgical Centers
• Research Laboratories
• Academic Institutes

By Country: 

• Brazil
• Mexico
• Argentina
• Chile
• Rest of Latin America

Geographically, the Latin America Atherectomy Devices Market is predicted to show significant growth in the forecast period due to developing economies like Brazil and Mexico. The Brazilian market is expected to play a dominating role in the Latin America Atherectomy Devices Market during the forecast period. Because of the rising incidence of cardiovascular diseases (CVDs) resulting from tobacco use, poor diet, and physical inactivity, there may be a greater need for atherectomy devices to treat CVDs. In addition, there has been a considerable increase in the number of patients recuperating from atherosclerosis, obesity, and cancer. The number of people having angioplasty, treatments, and catheterization to decrease Arterial Plaque has been steadily increasing. The penetration of atherectomy devices is expected to increase as collaborations between major manufacturers in the Atherectomy Devices Market and worldwide distributors grow. The growing demand for atherectomy devices has resulted in a concentration of atherectomy devices in these areas. The Atherectomy Devices Market's advanced technology-related nature provides lucrative business opportunities for market participants who aim to launch technologically enhanced atherectomy devices. Over the forecast period, the rising incidence of vascular diseases and disorders related to or caused by calcified peripheral and coronary arteries reduced blood flow, and lower-limb amputation is expected to fuel demand for atherectomy devices, which is also expected to grow at a rapid rate in the coming years.

KEY MARKET PLAYERS:

A few of the prominent companies leading in the Latin American Atherectomy Devices Market profiled in the report are Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Avinger, Inc., Boston Scientific Corporation, Straub Medical AG, St. Jude Medical, Cardiovascular Systems, Inc., and Spectranetics.